FDA Clears AIOMEGA’s AIO Breathe, for Treatment of Obstructive Sleep Apnea
AIOMEGA , a Texas biomedical company, announced that AIO BREATHE, their medical device that treats Obstructive Sleep Apnea, has been cleared by the Food and Drug Administration.
- AIOMEGA , a Texas biomedical company, announced that AIO BREATHE, their medical device that treats Obstructive Sleep Apnea, has been cleared by the Food and Drug Administration.
- AIO BREATHE is a “new mandibular repositioning device” designed by Tyler, Texas based Board Certified Sleep Physician Dr. Raghavendra V. Ghuge , MD, MBA, DABSM, FAASM.
- “I designed AIO BREATHE, supported by multiple patents, to overcome several shortcomings of conventional oral appliances used for treatment of OSA,” said Dr. Ghuge
AIO Breathe acts by increasing the patient’s airway during sleep, improving ability to exchange air, thereby reducing the tendency to snore and alleviating signs of obstructive sleep apnea. - AIO Breathe is intended to reduce or alleviate snoring and mild to moderate Obstructive Sleep Apnea (OSA) while sleeping in adults.